# Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome

> **NCT04169776** · NA · COMPLETED · sponsor: **Northwell Health** · enrollment: 7 (actual)

## Conditions studied

- Idiopathic Nephrotic Syndrome
- Frequently Relapsing Nephrotic Syndrome

## Interventions

- **DEVICE:** Transcutaneous Auricular Vagus Nerve (taVNS) stimulation

## Key facts

- **NCT ID:** NCT04169776
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-01
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04169776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04169776, "Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04169776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*